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 Chapter 7 
 Vulnerability and Marginalized Populations 
 Anthony  Wrigley and  Angus  Dawson 
7.1  Introduction 
 Public health practitioners attempt to identify and then remove, or at least reduce, 
threats of harm. However, harm does not affect everyone in the same way. Some 
people and communities are resilient, whereas others are more susceptible to poten-
tial harm. Much public health work is carried out by, or on behalf of,  government s. 
Where people or communities are at great risk of harm, government has a clear and 
fi rm responsibility to protect its citizens. One way of describing a potential source 
of such a risk of harm is to focus on the idea of  vulnerability . This introduction 
explores the concept of ‘vulnerability’ and the role that it may play in public health. 
 Vulnerability is a concept often used in public health ethics and more broadly in 
 bioethics —but its exact meaning is unclear. Roughly, it indicates that an individual 
or group is thought to have a particular status that may adversely impact upon their 
well-being, and that this implies an ethical  duty to safeguard that well-being because 
the person or group is unable to do so adequately themselves. This concept, although 
important, consistently eludes precise defi nition. The diffi culty in defi ning the con-
cept arises from disagreement as to how to characterize the idea of “special status” 
and to whom it applies. As a result, more and more categories of individuals and 
groups are being classifi ed as vulnerable in an ever-increasing range of situations. 
This raises the concern that almost everyone can be classifi ed as vulnerable in some 
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way and, in turn, that almost every activity now requires this additional attention. If 
true, then the concept of ‘vulnerability’ ceases to be useful because if everyone is 
vulnerable, then no one is. 
 There is currently no clear, single, defi nitive account of this concept that is univer-
sally accepted, although numerous different approaches have been adopted by, for 
example, various international bodies in their  guideline s. In this chapter, we shall 
critically examine some leading defi nitions of vulnerability and attempt to explain 
and classify them to make clear the differences in approach. Then we will offer an 
account of vulnerability that seeks to provide a universal basis for the everyday use 
of the concept while avoiding the pitfalls associated with the other defi nitions. Our 
approach aims to reduce the concept to a simple role, not as a basic moral concept in 
its own right, but as a marker, or signal, to public health practitioners that something 
in the situation before them requires ethical attention. The real ethical work is to be 
done by the practitioner, not by vague appeal to the idea of vulnerability, but via the 
application of other concepts and ethical concerns that are already familiar in public 
health and  bioethics .  We shall use case studies to illustrate how this approach works. 
7.2  Different Approaches to the Concept of Vulnerability 
 Before looking at the approaches taken to defi ne vulnerability, a worthwhile starting 
point is to examine the concept that can be derived from the term’s everyday use. 
Vulnerability, in line with the etymological root of the word meaning “to wound,” is 
widely interpreted as
 ( V1 ) Open to harm or under threat of harm. 
 This basic defi nition is perfectly adequate, for a range of uses, with context deter-
mining the nature and kind of harm at stake. However, such a defi nition only captures 
a broad background use as to how the concept should be employed. Though this defi -
nition will be suffi cient for most purposes, further clarity and greater specifi city of the 
concept is needed here. In attempting to refi ne this basic defi nition, several challenges 
arise. First, how we formulate any defi nition will change whether or not we see some-
one as vulnerable. Therefore, in providing a more substantial defi nition, one has to 
avoid the problem of inadvertently excluding those who should be considered genu-
inely vulnerable or including those who are not vulnerable. Second, if we want the 
concept of vulnerability to function as something that generates a  duty or responsibil-
ity to prevent  harms from befalling people, then we must move beyond a basic, factual 
description and include some normative ethical element, something along the lines of 
what Goodin  c haracterizes as “the principle of protecting the vulnerable” ( 1985 , 110). 
 Providing a sound defi nition of  v ulnerability that satisfi es these elements is more 
diffi cult than might be expected.  Hurst ( 2008 ) captured this diffi culty well by liken-
ing it to the attempts of six blind men trying to describe an elephant. As each blind 
man touches a different part of the elephant—the trunk, ear, tusk, tail, etc.—they 
cannot agree on how to describe the animal. This analogy maps directly to the chal-
lenge of defi ning vulnerability. Because different perspectives abound on what con-
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stitutes the grounds of vulnerability, consensus on the defi nition is diffi cult to reach 
(Schroeder and Gefenas  2009 ). 
 Much of the focus on vulnerability in the  bioethics literature has been in  research 
ethics, where many international guidelines recommend or impose some duty to 
provide extra protection for those considered vulnerable. However, these  guideline s 
generally fail to defi ne the concept (although the  Council for International 
Organizations of Medical Sciences [CIOMS] ( 2002 ) does provide a defi nition) and, 
instead, list groups commonly  considered  vulnerable (U.S. Department of Health, 
Education, and Welfare  1979 ; World Medical Association  2013 ; CIOMS  1993 ). 
Although this practice is slowly changing, strategies for analyzing and defi ning the 
concept are usually limited to simply adding or subtracting from a  list  of properties, 
conditions, or categories that typify what it is to be considered vulnerable. 
 The approaches taken to defi ne vulnerability beyond everyday use ( V1 ) can be 
categorized broadly into three basic types:
 ( V2 ) Vulnerability is a universal condition that humanity has in virtue of our physi-
cal or social nature (Fineman  2008 ; Hoffmaster  2006 ; Turner  2006 ; Rogers et al. 
 2012 ; MacIntyre  1999 ; International Bioethics Committee of UNESCO [IBC] 
 2013 ; and to  s ome extent Hart  1961 ). 
or
 ( V3 ) Vulnerability involves one or more specifi c attributes, contexts, or group types 
(Rendtorff  2002 ; and this is perhaps also the approach taken by the International 
Bioethics Committee of UNESCO when it considers what it calls special vulner-
abilities,  2013 , 5–6). 
or
 ( V4 ) Vulnerability involves one (or more) familiar but overarching ethical  conc ept(s) 
(Goodin  1985 ; Wrigley  2010 ). 
 Before we critically examine each approach, it is worth noting that all defi nitions 
are perfectly adequate depending on what we want the concept to do or what role 
we want it to play. One possible explanation for the failure to produce a single, uni-
versally agreed-upon defi nition of this concept is that, put simply, those who use the 
term have different aims and roles in mind. 
7.3  Concerns Surrounding Approach (V2): Universal 
Condition 
 Approaches to the concept along the lines of ( V2 ) use vulnerability to mark every 
human as somehow open to harm—including physical injury, dependency on oth-
ers, loss of power, and so forth—just by virtue of being human (Fineman  2008 ). 
Hence, by that logic, everyone is vulnerable because we all have bodies that can be 
injured, disabled, and fail through illness and old age. On this view, we are also 
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vulnerable because whilst we live in social units that require  interdependence , high 
quality interaction does not always exist. 
 ( V2 ) is a very particular way of thinking about the concept of vulnerability inas-
much as it motivates and drives discussion of the human condition in general. However, 
the major problem with such accounts is that the general truth that we, as humans, are 
open to  harms of various kinds or that we live in social groups, fails to pick out a spe-
cial category because it applies to absolutely everyone. It becomes diffi cult to talk of 
‘ degrees ’ or ‘ types ’  of vulnerability on such accounts. This, in turn, has led to the criti-
cism that such an approach results in the “naturalizing” of the concept, whereby it is 
held to be normal or natural to be vulnerable in one way or another (Luna  2009 ). Of 
course, if the idea behind using the term ‘ vulnerable ’ is ( a ) to articulate a fundamental 
aspect of the human condition, ( b ), to say something substantive about the interdepen-
dence of humans, and, perhaps, ( c ) to thereby affi rm a natural commitment to human 
 solidarity , then much substantive (and controversial) content is built into the concept, 
and our discussion moves far from the everyday meaning of vulnerability. If we are all 
vulnerable, then appealing to this concept as a means to avoid a harm or seek special 
protection becomes problematic, as it is hard to see how particular priorities can be set. 
 This approach makes vulnerability far too broad to serve as anything other than 
an underlying presumption about all human beings, and so it is unable to generate 
ethical  duties beyond what we owe to every human by virtue of being human. As a 
result, this approach does not provide an account of vulnerability that can identify 
cases where people or groups are potentially open to harm in any special way. 
7.4  Concerns Surrounding Approach (V3): Specifi c 
Attributes, Contexts, or Groups 
 In direct contrast to the approach taken in ( V2 ), ( V3 ) characterizes vulnerability by 
identifying it with some specifi c attribute, context, or group membership. This 
approach focuses on vulnerability  in terms of something , such as physical vulnera-
bility, social vulnerability, vulnerability  in terms of lacking capacity, vulnerability  in 
terms of belonging to a certain identifi able group, or vulnerability because of 
belonging to a marginalized population, etc. 
 This approach to defi ning the concept is an excellent way of illustrating the sorts 
of conditions that we might want to pick out as requiring special consideration in 
terms of susceptibility to harm. As such, ( V3 ) serves as a useful heuristic device 
because it gives examples of the sorts of things that are often considered vulnerabili-
ties. However, this check-list approach is to  borrow  David Lewis’s ( 1986 ) phrase, an 
attempt at explanation by “way of example,” whereby we provide some key para-
digmatic examples or illustrations of what constitutes vulnerability and state that 
vulnerabilities are “these sorts of things.” 
 This approach does a poor job of defi ning vulnerability. Listing everything that 
falls under a concept, even if it were possible, does not give us a good defi nition of 
that concept. ( V3 ) neither tells us whether the examples listed are appropriate nor 
guides our decision making on controversial cases where identifying someone as 
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vulnerable is unclear. Further, by using the ( V3 ) approach, attention is directed 
away from the underlying question of what vulnerability  is ; and instead, the focus 
is on whether or not to add a particular group to a continually expanding unstruc-
tured list of examples (Rogers et al.  2012 ). Of course, any such list might prove 
useful as an aide memoir during, for example, an emergency event. Such a prag-
matic role may be useful, but it should not be mistaken for  an  ontological category 
or conceptual boundary. 
 The ( V3 ) approach has therefore met with the criticism that it is both too broad 
and too narrow to satisfactorily defi ne vulnerability (Levine et al.  2004 ; Schroeder 
and Gefenas  2009 ; Luna  2009 ). Concerns about being too broad stem from the list 
of vulnerabilities becoming infl ated to the point where “virtually all potential human 
subjects are included” (Levine et al.  2004 ). As such, the same concern for ( V2 ) 
applies to ( V3 ), since both approaches fail to specify in suffi cient detail those who 
need additional or special protection from  harms . 
 ( V3 ) is also, potentially, too narrow because it focuses all attention onto specifi c 
or group characteristics and therefore fails to address concerns outside the particular 
designated categories (Rogers et al.  2012 ). It will, therefore, potentially miscatego-
rize certain individuals or groups as  not being vulnerable if, for example, they are a 
group that has not been encountered previously or if some trait has not made it onto 
the list of specifi ed characteristics. Moreover, by focusing on specifi c or group char-
acteristics, ( V3 ) can stereotype individuals who fall under category headings (Scully 
 2013 ). If, for example, we assign names to different categories of vulnerability (e.g., 
‘the elderly’, ‘the disabled,’ or ‘women,’ or ‘the poor’ as categories of vulnerabil-
ity), then many people could be classifi ed as vulnerable without them necessarily 
being at any greater risk of harm. 
7.5  Concerns Surrounding Approach (V4): Overarching 
Concepts 
 The ( V4 ) approach explains vulnerability in terms of one or more overarching but 
more familiar ethical concept(s). Perhaps the best example of this kind is  Goodin ’s 
( 1985 ) account of vulnerability, which builds on the everyday use of the term 
( V1 )— open to or under threat of harm— but goes a step further by exploring what 
the relevant harms might be. This leads Goodin to interpret “harm” in terms of a 
person’s “welfare” or “interests” so giving us an initial defi nition of being vulnera-
ble in terms of ‘ being susceptible to harms to one ’ s interests ’( 1985 , 110–114). 
 However, as the concepts of ‘welfare’ and ‘interests’ can in turn be open to a 
great deal of interpretation, including the possibility of focusing on subjective expli-
cations involving the satisfaction of preferences or desires, further clarifi cation is 
needed. To this end, Goodin suggests that a particular sub-group of interests, that 
is—people’s “vital interests” or “needs”—are the universally important welfare 
considerations that we need to be concerned about. On this view, one is vulnerable 
if one’s needs are threatened. And one is most vulnerable if one’s most  vital  needs 
are threatened. 
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 Goodin also adds an explicit normative role to the concept of vulnerability by 
imposing an ethical  duty to safeguard the potentially vulnerable from harm. This 
role is imperative if the concept of vulnerability is to be anything more than a factual 
description of an individual’s or a group’s characteristics. Goodin does this by link-
ing his account of vulnerability to the “principle of protecting the vulnerable,” 
which is, essentially, an  obligation to protect the vital interests of others. Hence 
there is a direct link between the classifi cation of someone as being vulnerable, with 
a requirement on the part of others to protect them from any potential harms. 
 Despite being a highly infl uential account of vulnerability, this approach has 
been criticized. One concern is that it potentially promotes widespread  paternalism 
in an attempt to meet others’ needs (Rogers et al.  2012 ), thereby characterizing all 
vulnerable people as, in some way, being helpless. This criticism misses the mark, 
though, because being vulnerable by Goodin’s account does not mean one is power-
less. More telling, however, are the concerns that this account does nothing more 
than reduce the concept of vulnerability to the well-recognized concept of needs, 
together with a moral theory that demands we aid those in need. In essence, this 
implies that the concept of vulnerability is redundant and could be replaced with the 
concept of being in (serious) need. 
7.6  Simplifying the Concept of Vulnerability (V5): 
The Moral-Marker Approach 
 Rather than continuing this attempt to defi ne vulnerability along the lines of the 
approaches already mentioned ( V2 ,  V3 ,  and V4 ), an account of vulnerability can be 
offered in much simpler terms. Instead of seeking a substantive defi nition that tries 
to establish conditions for vulnerability, another option is to interpret the word “vul-
nerability” as nothing more than an empty marker or signal for potential moral 
concern. This approach can be seen in  Hurst’ s view of vulnerability as a sign of 
“increased likelihood of incurring additional or greater wrong” ( 2008 ). However, 
this view can be taken further. A formal moral-marker approach simplifi es the 
account of vulnerability by avoiding any reliance on moral theory or preconceived 
wrongs as part of the defi nition. On this account,  vulnerability will simply be
 ( V5 ) A marker that additional consideration needs to be given to whatever existing 
ethical issues there may be. 
 It can be seen that what is then in dispute between the different accounts presented 
is what sorts of considerations are the relevant ones. However, if we stop at the point 
where “vulnerability” is recognized as just a warning marker, we don’t need to 
engage with the substantial task of trying to provide a catch-all defi nition that some-
how incorporates all physical, mental, or emotional, etc. cases that might constitute 
vulnerability. Instead, we can focus on substantive ethical concepts such as harm, 
consent, exploitation, etc. and explore how each applies to the particular case before 
us. On the basis of this approach, “vulnerability” says nothing at all about what gen-
erates the need for any special scrutiny because the substantive  ethical weight of the 
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concern (and how to address it) requires us to engage with these substantive moral 
concepts. So, for example, it says little to talk about marginalized populations as 
being vulnerable, but if we recognize the ‘moral marker’ of  vulnerability here, we 
might then explore how exploitation,  inequity , and harm are relevant when deliberating 
about a particular case. One of the priorities for educating public health  profession als 
about ethical issues is to seek to increase their sensitivity to the relevant features of 
each situation, rather than teach them the formulaic application of rules or vague 
concepts such as that of “vulnerability” (Coughlin et al.  2012 ). 
 The ( V5 ) approach offers other advantages as well. For example, it avoids stereo-
typing based merely on belonging to a specifi ed category; it avoids exclusion on the 
grounds of not already being on the list of vulnerable groups; and it avoids the vacu-
ity of identifying “all” as vulnerable, while maintaining the crucial aspect that the 
concept marks out the need for special ethical scrutiny. Trying to provide more 
substantial components to the defi nition  of  vulnerability diverts scrutiny and energy 
from where it matters most—sensitive, rational thought about specifi c problems—
and instead, promotes a formulaic approach to ethical safeguarding. 
 Although other writers on vulnerability, such as Levine et al. ( 2004 ) and Luna 
( 2009 ), criticize this approach claiming generic guidance about paying “special atten-
tion” or giving “special consideration” to something is not useful, the same criticism 
could also apply to an account that identifi es specifi c categories or relies on some over-
riding concept. For example, if we try the specifi c category or context route ( V3 ) so 
that, say, we hold “the elderly” vulnerable, how would that guide our actions without 
reference to established concerns about, for example, physical  harms or exploitation? 
The same holds true of ( V4 ) accounts such as  Goodin ’s focus on vulnerability as being 
open to harms to one’s interests, which then requires further analysis of “vital” needs. 
The best that can be said for such accounts is that each provides something of a heuris-
tic, teaching anyone who wants  to  learn ways in which harms or wrongs might arise. 
 The importance and implications of these issues become apparent as we consider the 
various cases in the rest of this chapter. The implications of ( V2 ), the approach focused 
on vulnerability as arising from the human condition, is that all are vulnerable, includ-
ing the police and  immigration offi cials in Blight’s and McDougall’s cases, the public 
health offi cials with responsibility for launching national programs to reduce  Sudden 
Infant Death Syndrome (SIDS) in the Jonas and Haretuku case, and the prison governor 
in Christopher et al.’s case. This outcome demonstrates the key problem with this view. 
The very concept of vulnerability ceases to have much meaning, although presumably 
there might be a retreat to the thought that some individuals and populations are ‘more’ 
vulnerable than others, although it is unclear how this is to be specifi ed. 
 Many of the cases could more obviously be used to endorse ( V3 ), the approach 
focused on specifi c groups, contexts, or categories. Many of these cases focus on 
marginalized groups within society, such as prison  inmates (Christopher et al.), 
immigrants,  asylum seekers ,  refugees (McDougall; Blight), substance abusers 
(Christopher et al.), minority communities of various kinds (Bernard et al.; Blight; 
Jonas and Haretuku), and the poor (Vergès et al.). This is a traditional, infl uential, 
and powerful way of thinking about vulnerability. However, as stated previously, 
this approach has its problems. Does it necessarily follow that if you belong to one 
of these groups that you are vulnerable? You may well be at increased risk of harm 
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of various kinds if you belong to such groups. However, you might also be at 
increased risk of harm as a recreational drug user, skydiver, or American football 
player, although individuals belonging to such groups are not likely to be seen, 
intuitively, as being necessarily vulnerable. 
 The more specifi c focus on providing a normative explanation for vulnerability pre-
sented in the work of writers such as  Goodin ( V4 ), is more useful, in that we can begin 
to clearly identify subgroups that are at risk of harm to their vital interests (the girl fed 
through a tube and unable to feel pain involved in a forced  deportation case: Blight), 
rather than just being routinely disadvantaged (the surrogate encouraged to take on that 
role because of poverty: Vergès et al.) or at increased risk of harm due to the cultural 
traditions or choices of their  parent s (Jonas and Haretuku). How should we think about 
risk factors and vulnerability? Some will think of  smoking around  children (increasing 
the risk of SIDS) as being an individual’s choice. Others will argue that it is unfair to 
assume that it is always individuals that are responsible for such choices and the 
resultant outcomes, as people may be addicted to nicotine or they may have  become 
 smokers through the infl uence of  norms within their social environment. 
 The advantage of the ‘moral-marker’ approach ( V5 ) is that it allows us to dive 
beneath the surface offered by the label of ‘vulnerability’ and offer more sophisticated 
explanations for the situations described in the cases, as well as providing the oppor-
tunity to develop strong normative reasons to respond. For example, all of these cases 
are about various kinds of injustice, disadvantage, and inequities in society, and their 
impact on individual and  community health . They are appropriate issues for those 
working in public health to be concerned about precisely because they provide refer-
ence to the identifi cation of various  harms at the population-level, and many of the 
solutions to these issues will have to come through collective and public action. 
 As the discussion of the different approaches to defi ning vulnerability consid-
ered above illustrate, most of the approaches to vulnerability do little more than 
encourage us to engage in additional ethical scrutiny using already well recognized 
and well understood moral concepts. The fi nal ‘moral-marker’ approach ( V5 ) sug-
gests that this is exactly what the concept should be used for, and nothing more. 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
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 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
7.7.1  Background 
 Sudden Infant Death Syndrome (SIDS) involves the death of apparently healthy 
sleeping infants, usually within the fi rst year of life. It is a diagnosis of exclusion, 
that is, it denotes an unknown cause of death (Willinger et al.  1991 ; American 
Academy of Pediatrics  2011 ). It is also known as cot or  crib death and is  classifi ed 
 as a form of Sudden Death in Infancy (SUDI). 
 Unlike many public health issues, SIDS unites clinical and forensic considerations, 
as this fi nding of cause of death can determine attribution of criminal (and moral) 
responsibility. Police collect evidence and coroners assess the circumstances of the 
death and release judgments. This is the method by which a SIDS death is determined. 
Context heightens the ethical signifi cance of SIDS diagnosis, research, and  prevention . 
 In 1991, when the New Zealand Cot Death Study (NZCDS) commenced, New 
Zealand’s rate of SIDS was high by international standards at 4 deaths per 1,000 live 
births (Mitchell et al.  1997 ) compared, for example, to the  Netherlands (1.3/1,000 in 
1989) (de Jonge et al.  1989 ) and Hong Kong (0.3/1,000 in 1986–1987) (Lee et al. 
 1989 ). Within New Zealand, SIDS deaths occurred in the indigenous  Māori popula-
tion at twice the rate of the non-Māori population (Mitchell et al.  1994 ). The reason 
for this signifi cant disparity was not  well understood. 
 The NZCDS was the fi rst national  case-control study designed to identify risk 
factors for SIDS. By comparing  infants whose deaths were attributed to SIDS with 
a representative sample of live births, within a year, the NZCDS had identifi ed a 
number of risk factors. The study confi rmed an association between increased risk 
of SIDS and lower socioeconomic status, along with a range of associated maternal 
factors, including fewer years of education, younger age at fi rst  pregnancy , greater 
number of previous pregnancies, and lower attendance at prenatal classes (Mitchell 
et al.  1991 ). The NZCDS selected three risk factors to address among this range of 
fi ndings: lack of  breast-feeding , maternal  smoking , and placing infants to sleep in a 
prone position (Mitchell et al.  1991 ). 
 The ensuing national  prevention campaign focused on publicizing these risks, 
which  parent s were seen as able to infl uence. These were categorized as ‘ modifi able 
risk factors .’ Many parents changed their practices in response to the campaign (Cowan 
 2010 ). Abandonment of the prone sleeping position was the most readily and widely 
adopted measure and is credited with delivering the largest proportion of the national 
reduction in SIDS rates (Mitchell et al.  1997 ). Factors that were less susceptible to 
parental alteration were classifi ed as ‘ nonmodifi able risk factors .’ Nonmodifi able fac-
tors included the baby’s sex, the mother’s age, and the family’s socioeconomic status. 
 Analysis of the second year’s data revealed another risk factor: bed-sharing 
(Mitchell et al.  1992 ). Bed-sharing was  categorized  as a  modifi able risk factor , and 
 parent s were advised to avoid sleeping on the same surface as their baby or allowing 
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others (for instance, other  children ) to do so. The study’s fi ndings were immediately 
fed into the  prevention campaign. 
 Communicating with parents about this particular risk factor became more prob-
lematic than initially anticipated. The diffi culties partly refl ected a developing under-
standing about the subtle nature of bed-sharing risk. While early messages counselled 
against all bed-sharing, subsequent fi ndings prompted adjustments (Cowan  2010 ). 
Now bed-sharing is not viewed as a signifi cant risk unless coupled with maternal 
 smoking or with the baby’s bedmate being intoxicated or excessively tired. Other 
factors such as the baby’s age, the site, and duration of bed-sharing have also been 
identifi ed as affecting the magnitude of risk. These considerations make it diffi cult to 
summarize the risk in a way that is scientifi cally sound and that parents can easily 
understand. Also, the prevention campaign took place against a backdrop of numer-
ous changes in prevailing thought since the 1950s about the causes of SIDS. These 
changes were associated with changing advice about parental practices, which cre-
ated uncertainty  within families about which advice should be followed. 
 The cultural signifi cance attributed to bed-sharing meant that there were differ-
ent reactions among groups to advice not to bed-share. While bed-sharing is not 
traditional among  New Zealand European (Pākehā) families, it is fi rmly rooted in 
Māori and Polynesian child-rearing practices (Tipene-Leach et al.  2000 ). In these 
communities, bed- s haring is seen as positive and benefi cial, promoting bonding 
between mother and child and enabling mothers to comfort and care for their child 
(Abel et al.  2001 ; Tipene-Leach et al.  2000 ). The message that bed-sharing is risky 
had serious implications, then, for Māori and Polynesian child-rearing practices. 
 The early years of the SIDS  prevention  campaign succeeded in reducing the rate 
of SIDS, but the tenor of the anti-bed-sharing message alienated many, particularly 
indigenous Māori, consequently turning whānau (wider family networks) away 
from SIDS prevention messages altogether (Stewart et al.  1993 ; Tipene-Leach et al. 
2000; Cowan  2010 ). Some interpreted the campaign as blaming Māori for  infant 
deaths. After an infant death, the involvement of police, pathologists, and a coro-
ner’s court compounds overtones of culpability, intensifying the guilt and grief 
associated with the loss of a child (Clarke and McCreanor  2006 ). 
 Several years after the ongoing SIDS prevention campaign was launched, rates 
of SIDS among Māori remained disproportionately high. In 2009, the rate of SIDS 
for Māori was 1.5 per 1,000 live births, compared with 0.6/1,000 for Pacifi c Peoples, 
and 0.3/1,000 for Other, including Pākehā (Ministry of Health  2012 ). 
 Several  modifi able risk factors for SIDS, including maternal  smoking and bed- 
sharing, are more prevalent in the Māori community. Māori  parent s less frequently 
attend prenatal classes than non-Māori parents. Along with the modifi able factors, 
many nonmodifi able factors are more likely to apply to Māori families, including 
lower socioeconomic status, younger age of mother at fi rst  pregnancy , greater num-
ber of pregnancies, and fewer years of education (Mitchell et al.  1993 ). These con-
tributors to rates of SIDS among Māori do not receive the same level of scrutiny in 
the media as modifi able parental practices, and  prevention campaigns continue to 
focus upon  altering  parental practices. 
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 A sense of injustice and a perception that the state lacks a true commitment to 
addressing the societal factors underpinning SIDS prevails in parts of the Māori 
community. The prevention campaign’s focus upon discouraging bed-sharing con-
tributes to the community’s sense that the campaign undermines rather than sup-
ports traditional Māori practices. In particular, the coronial process—the 
investigations into the cause of death, the invasive process of autopsy, and the slow 
return of the body to whānau—cannot easily accommodate the deep-felt need of 
whānau to complete the traditional Tangihanga process, the spiritual rituals and 
burial proceedings following a death (Clarke and McCreanor  2006 ; McCreanor 
et al.  2004 ). Nor is the high profi le of the bed-sharing risk matched by a  commitment 
to tackle other risk factors, which may require more resources. Some have therefore 
called for examination of the process by which risk factors are categorized as modi-
fi able or nonmodifi able (Tipene-Leach  2010 ; McManus et al.  2010 ). 
 The  government has committed substantial resources to culturally appropriate 
SIDS prevention for Māori and Polynesian families and is conducting trials of 
appropriate supports for families  to  bed-share safely (Tipene-Leach  2010 ). 
Meanwhile, criminal proceedings against Māori  parent s relating to the deaths of 
their  infants while co-sleeping continue to receive media attention (R v Tukiwaho 
2012; APNZ  2013 ). No wonder, then, that the strong sense of parental responsibility 
for SIDS deaths, where bed-sharing is a factor,  remains. Although inequities under-
write the high exposure of Māori families to both modifi able and nonmodifi able risk 
factors, both government-funded  health promotion and media coverage of SIDS 
remain focused on parental practice. 
7.7.2  Case Description 
 Following high-profi le media coverage of the greater burden of SIDS among Māori, 
new funding is available for a SIDS prevention campaign to reduce SIDS in Māori 
and Polynesian families. Part of this funding is reserved for the generation of new 
 guideline s acceptable to Māori. There is also an opportunity to brief the Minister of 
Health and the Minister of Social Development about measures that can reduce 
rates of SIDS deaths among  Māori  infants. 
7.7.3  Discussion Questions 
 1.  Evidence suggests that several factors affect the magnitude of risk and that bed- 
sharing in the absence of these factors does not signifi cantly increase the risk of 
SIDS. But the interplay of risks can be complex and diffi cult to communicate 
effectively in a national campaign.  Can a defi nitive “no bed-sharing” message be 
defended, on ethical grounds, if it causes less confusion but overstates the risk to 
some groups? What are the most important ethical considerations here? 
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 2.  What weight should be attributed to the cultural signifi cance of bed-sharing 
when generating  guideline s, and why? Should risks that relate to culturally sig-
nifi cant parental practices, such as bed-sharing, be treated differently from risks 
relating to practices that are not held to be culturally signifi cant? 
 3.  Māori and Polynesian families value bed-sharing because of the health and 
social benefi ts they attribute to it. These benefi ts are not captured in studies 
investigating SIDS risk. Should the health and social benefi ts attributed to 
bed-sharing by families who practice it be accorded weight when formulating 
guidelines? If so, how much weight? If not, why not? 
 4.  Colonization has imposed and continues to impose an assault upon Māori cul-
ture. Anti-bed-sharing advice might be seen to extend that assault, privileging a 
narrow range of health concerns. The inherent beliefs and practices that led 
Māori to value bed-sharing, such as bonding between mother and child that pro-
motes strong social bonds, seems particularly worth preserving. How can respect 
for Māori social practices and ways of viewing the world inform SIDS-related 
health promotion? How much difference does the magnitude of the relevant 
health risk make? If the risk is less serious, would you favor a different approach? 
 5.  Consider how risk factors might be categorized as modifi able or nonmodifi able. 
What role should fairness play in this process? 
 6.  Consider the role guidelines might play in coroners’ investigations to identify 
contributing factors to an infant death. Should this possibility be kept in mind 
when guidelines are being drafted?  Why? Why not? 
 7.  Does parental responsibility require compliance with child health guidance? 
How should parents evaluate confl icting or changing advice about risk? 
 8.  Parents can control some risk factors for SIDS, but others involve broader soci-
etal issues, such as socioeconomic status. Does social  justice require that  preven-
tion campaigns targeting parental practices be coupled with efforts to tackle 
social and economic disparities and inequities? Who should be responsible for 
ensuring that this is the case? What should researchers do when they identify a 
parental  pract ice as risky if resourcing for broader action is not forthcoming? 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
7.8.1  Background 
 Advances in  biotechnology regularly generate novel ethical challenges that fall 
between the cracks of safeguards designed for conventional cases. Innovations—
especially  in  reproductive technologies—can even create new classes of vulnerable 
people. Such novel cases often force us to thoroughly reexamine ethical safeguards 
and reveal the legal and ethical gaps. 
 Panama , like most Latin American countries, divides its health care system into 
public and private systems. Public insurance covers roughly 81 % of the population 
(Contraloria de la Republica de Panamá  2012 ). Families lacking permanent work 
and unable to afford insurance can fi nd public assistance for health services through 
the Ministry of Health (MoH). The MoH by  law regulates most health research and 
health services, including  regulation and supervision of hospitals and public and 
private clinics (Asamblea Nacional de Panamá  1947 ). The private system, although 
legally supervised by the Ministry of Commerce, exists mostly free of external con-
trol and relies heavily on self-regulation. Medical doctors, after initial MoH certifi -
cation, are no  longer  monitored (Decreto de Gabinete  1970 ). 
 Like the certifi cation process, the ethical guidance that applies to doctors is not 
overseen. Although a Panamanian Medical College code of ethics has applied to 
doctors since 2009, its ethics committee meets only to consider malpractice charges 
brought against doctors (Colegio Médico  2012 ). Independent associations for medi-
cal specialties exist, but they focus on academic and social matters, not on public 
health issues. Only recently have some associations begun to discuss the ethical, 
legal, and social implications of their specialty-related health topics such as trans-
plantation, blood banks,  storage of biological tissues, sale of organs for transplant, 
and rights and  obligations of organ donors and recipients. 
 In response to a growing burden of  maternal mortality , sexually transmitted dis-
eases, and adolescent pregnancy, the World Health Organization in 2000 began a 
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sexual and reproductive health program (World Health Organization  2000 ). This 
initiative prompted the Panamanian  government to begin covering infertility prob-
lems and permitting the public health care system to treat married couples (Ministerio 
de Salud  2000 ).  Alt hough the MoH did not include  in-vitro fertilization (IVF) and 
 surrogate pregnancy in this program, a public institution, the Gorgas Institute for 
Health Research, announced in 2011 that it would launch an IVF program in 2013 
for couples with limited resources (Soto  2012 ). The government, however, was 
silent about IVF, so the  regulations governing IVF remain unclear. However, a  law 
governing organ transplantation, which permits donation of living cells, comes clos-
est to offering legal guidance for IVF. This law requires the donor and recipient to 
give written  consent but does not permit the donor to receive  compensation . Nor 
does it protect the health and confi dentiality of the donor and recipient or offer treat-
ment of medical complications (Asamblea Nacional de Panamá  2010 ). Nowhere, 
does this law or any other address surrogacy. 
 Medical tourism is a new and growing industry in  Central America , where a 
quarter of the world’s medical tourism occurs (Martinez  2011 ). At 16 %, Costa Rica 
commands the largest industry share in Central America; but according to estimates 
of its National Science and Technology secretary,  Panama will achieve a 12 % share 
in 2015 through services offered by its four private hospitals. At these hospitals, 
medical tourism may represent nearly 20 % of the patients being treated. The 
patients, who come mainly from Canada and the  United States , usually seek surgery 
for orthopedic problems, infertility, and cardiac disease. Although private advertise-
ments for medical tourism have been appearing since 2007 (Sbwire  2013 ), lawmak-
ers have not yet created a national legal framework to address the issue. 
 Couples  from neighboring countries or the  United States come to Panama seek-
ing infertility treatment because it is inexpensive, is largely unregulated, and per-
formed by Panamanian doctors noted for technical ability. Moreover, anyone who 
travels to Panama for treatment is entitled to receive it. IVF using fertilized eggs 
from anonymous donors has become standard practice, but surrogacy is not offi -
cially offered. No medical or legal problems  with  IVF surfaced until 2011 when the 
Panamanian MoH was asked to weigh in on a high-profi le case of an abandoned 
child born with severe birth defects to a Panamanian woman acting as a  surrogat e 
for a foreign couple. 
7.8.2  Case Description 
 A Panamanian woman, who was married with two  children , had a primary  school 
education. She worked in her own home but was experiencing economic diffi culties 
because her husband could not fi nd permanent employment. Why she agreed to sur-
rogacy is unknown, but presumably economic considerations played a major role. 
Because her fi rst two pregnancies had presented no problems, she signed a surro-
gacy contract to carry the fertilized egg of a married couple who had traveled to 
 Panama seeking surrogacy services. Little is known about how the foreign couple 
and the Panamanian woman came to know each other, because no lawyer 
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participated in this transaction. Nor did the surrogate’s husband learn of the transac-
tion until after she had signed the contract. Why no one thought to include the hus-
band is a mystery. After signing the  informed consent form, the surrogate was 
inseminated in a private clinic in Panama. Doctors involved in the case state that 
they followed medical recommendations and obtained the informed  consent of the 
surrogate and the egg donor. Neither the procedure nor the pregnancy presented any 
problems, but the surrogate unexpectedly died after severe complications developed 
during delivery. These complications, which also caused hypoxia and convulsions 
in the  newborn , left him with severe cerebral paralysis. As a result of his birth 
defects, he will never walk or speak and will require care for the remainder of his 
life. 
 The couple rejected the child, arguing that the contract specifi ed “a healthy 
child.” The husband of the Panamanian surrogate also rejected the child claim-
ing it was neither his wife’s, nor his, especially as he had not participated in the 
contract. He also pleaded that he now had to cope with his wife’s death and 
raising two motherless children. Appealing to the MoH, the clinic sought state 
custody of the child. The MoH offered medical assistance, but it declined to 
accept long-term responsibility for the child. Instead, the MoH charged a ethics 
panel to  examine  the case and, pending its outcome, sent the child to a religious 
orphanage. 
 The  ethics panel has been charged not only with making a ruling on this case, but 
in recommending measures to regulate  surrogacy  in the future, particularly cases 
involving medical tourism. 
7.8.3  Discussion Questions 
 1.  In the context of surrogacy and medical tourism, who is responsible for raising 
this child, and who should pay for his care and upbringing? What role should 
 government and  profession al associations play in these cases? What is the 
responsibility of doctors involved in  such  practices? 
 2.  What measures should the  ethics panel recommend to protect vulnerable women 
in the future who have agreed to surrogacy? 
 3.  What ethical basis could justify compensation for surrogates or their families in 
the case of death or injury to the surrogate? 
 4.  What measures should the ethics panel recommend for protecting medically 
compromised and abandoned infants when surrogacy-involved pregnancy or 
delivery goes radically wrong? How should informed consent forms be modifi ed 
to anticipate such outcomes? 
 5.  Do cases of medical tourism require international regulation of medical tech-
nologies? If not, why not? If so, how should the panel’s ethical arguments be 
incorporated into legal agreements between countries to guarantee the protection 
of vulnerable populations? 
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7.9.1  Background 
 Inject ion drug use is a major public health problem, with an estimated 3.5 million 
users in the United States (Armstrong  2007 ) and 15.9 million users worldwide 
(Mathers et al.  2008 ). Between 24 and 36 % of U.S. adults addicted to heroin pass 
through the criminal justice system each year (Rich et al.  2005 ). Compared with the 
general population, injection drug users have higher rates of  HIV ,  tuberculosis ,  hep-
atitis B and C, and sexually transmitted diseases (Baussano et al.  2010 ; Nelson et al. 
 2011 ; Weinbaum et al.  2005 ). Injection drug use contributes to correctional and 
community-level transmission of these conditions and threatens public  safety 
because users frequently engage in criminal behaviors to support their drug use. 
 In the  United States , more than two million people are incarcerated (Glaze and 
Parks  2012 ), and an estimated 70–80 % of U.S.  inmates have at least one  substance 
abuse problem (Karberg and James  2005 ; National Center on Addiction and 
Substance Abuse at Columbia University  1998 ). At least 40 % of state and federal 
inmates injected drugs in the month before their arrest (National Center on Addiction 
and Substance Abuse at Columbia University  1998 ). Moreover, 95 % of drug users 
return to drug use within 3 years of release from prison (Marlowe  2006 ). Compared 
with the general population,  prisoners are nearly 13 times more likely to die of any 
cause in the 2 weeks after their release and 129 times more likely to die from an 
overdose (Binswanger et al.  2007 ). 
 Rates of incarceration are also  substantial ly higher among minority groups, with 
 African American males being more than 6 times as likely, and Hispanics males more 
than 2.5 times as likely, to be incarcerated than white males (Carson and Sabol  2012 ). 
African Americans and Hispanics also experience higher rates of conviction for drug-
related offenses than whites (Carson and Sabol  2012 ) despite comparable rates of 
injection drug use between whites and Hispanics and lower rates among  African 
 Americans (Substance Abuse and Mental Health Services Administration  2007 ). 
 Although  inmates make up only 0.8 % of the U.S. population, about 22–31 % of 
Americans with  HIV , 40 % with  tuberculosis , and 29–43 % with chronic  hepatitis C 
pass through the correctional system each year (Hammett et al.  2002 ; Weinbaum 
et al.  2005 ). In the general community and prison population, minority groups bear a 
disproportionately high burden of new  HIV infections and  hepatitis , particularly 
 amon g injection drug users (Blankenship et al.  2005 ; Centers for Disease Control and 
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Prevention  2013 ; Estrada  2002 ).  Successful strategies to limit the spread of  infectious 
disease , therefore, need to include interventions  with  effective substance abuse treat-
ment that target minority groups,  particularly  anyone with a criminal background. 
 Correctional programs that link  prisoners to treatment for  substance abuse and 
related illnesses upon reentry to the community may reduce risky behaviors that 
contribute to high post-release mortality rates, bring much-needed care to a vulner-
able and medically and socially disenfranchised population, and interrupt transmis-
sion of infectious diseases to the broader community. However, despite the lack of 
widespread access to such services during and after incarceration, perhaps the great-
est obstacle to effectively treating drug users is poor motivation. In the  United 
States , 95 % of people with untreated substance abuse fail to recognize the need for 
treatment (Substance Abuse and Mental Health Services Administration  2012 ). 
When people with substance abuse do present for care, it is often because of exter-
nal, coercive pressure (Fagan  1999 ). Indeed, coercive strategies have long been used 
for treating individuals with substance abuse who do not otherwise seek help (Nace 
et al.  2007 ; Sullivan et al.  2008 ). One common argument in favor of coerced treat-
ment is that it restores  autonomy to people who have lost their ability to control their 
addiction (Caplan  2006 ). Another reason coercion may be necessary, in at least the 
initiation phase of treatment, is because permanent cognitive defi cits can result from 
extended drug use (Sullivan et al.  2008 ). 
 The World Health Organization has concluded that legally coerced treatment is 
justifi ed if due process and effective and humane treatment are assured (United 
Nations  2010 ). Still, although compulsory substance abuse treatment is frequently 
used for  pretrial offenders, studies fi nd little evidence that it reduces subsequent drug 
use (Perry et al.  2009 ). Indeed, fi ndings are largely mixed about whether legally 
coerced substance abuse treatment—irrespective of a person’s criminal  justice 
involvement—works in different settings (Klag et al.  2005 ). Similarly, there are 
inconsistent fi ndings on the  effectiveness of coerced drug treatment in the U.S. crimi-
nal justice setting and concerns about a lack of experimental controls in those studies 
that suggest relative  effi ciency (Hough  2002 ; Marlowe  2006 ; Zhang et al.  2013 ). 
 Several  reviews conclude that coerced treatment is certainly more effective than 
no treatment (Hough  2002 ; Kelly et al.  2005 ; Marlowe  2006 ).  Eme rging data sug-
gest that coercive  substance abuse treatment for  parolees reduces rates of reincar-
ceration; however, data are lacking on whether other clinical outcomes are improved 
(Zhang et al.  2013 ). 
7.9.2  Case Description 
 You serve as the director of Substance Abuse Services (SAS) in a  western state in 
the  United States . Rates of substance abuse, particularly injection drug use, are 
higher than the national average. Several large cities in your state have among the 
highest rates in the country. SAS shares data and conducts collaborative  research 
with the Department of Correction (DOC) and other state agencies within the 
Department of Health (DOH), of which SAS is a branch. Your research efforts have 
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identifi ed  needle sharing among former  prisoners , most of whom are members of 
minority groups, as the source of most new community cases of  HIV and  hepatitis 
B and C. You also found that more than half of these infected prisoners do not con-
tinue treatment when released and have high rates of reincarceration. 
 Following aggressive implementation of a statewide prison-based screening and 
treatment program for  infectious diseases , your state has experienced a marked drop 
in prevalence of these diseases among prisoners. However, for three straight years 
rates have increased steadily and disproportionately among injection drug users, 
with rates rising faster among minorities. 
 To confront this problem, you have successfully worked with representatives from 
the DOC to offer methadone maintenance programs to opioid-dependent prisoners 
and have hired reentry specialists to help parolees get treatment for  substance abuse 
and infectious diseases upon release. Unfortunately, to date, only 10–15 % of recently 
released prisoners who are eligible for these voluntary services have used them. 
 The governor has issued a directive to think creatively and foster better interagency 
 collaboration so programs can be developed to reach the other 85–90 % of recently 
released  prisoners who inject drugs or have infectious illnesses. You have been 
appointed to a task force along with other high-level representatives of state agencies, 
including the DOH, DOC, Department of Parole, and Department of Mental Health, 
to identify and implement other potential solutions. One suggested policy option is to 
establish compulsory post-release substance abuse  treatment  as a condition of parole 
that would be linked with  v oluntary infectious  disease screening and treatment. Your 
own interagency  research  suggests a high rate  of  transmission of HIV and  hepatitis 
B and C from  needle sharing with  former  prisoners who have been incarcerated multiple 
times and have not been treated successfully. Accordingly, the target population would 
be recently released prisoners who have two or more incarcerations and at least one 
drug-related conviction, a  history  of injection drug use, and either HIV or hepatitis. 
7.9.3  Discussion Questions 
 1.  Given your research fi ndings that most new community cases of HIV and hepatitis B 
and C result from needle sharing with former prisoners, most of whom are minorities, 
how would you defend or object to this policy proposal given it will disproportion-
ately subject minority groups to compulsory treatment as a condition of their parole. 
 2.  If such compulsory drug treatment for prison releases is shown to have little 
impact on community rates of infectious disease, what effect would the program 
need to have on recently released prisoners for you to support its use? Given a 
parolee’s vulnerable status in society, would you support the program if it 
reduced criminal recidivism alone? If not, what other outcomes are important to 
you and why? Would outcomes have to be clinical, or could outcomes refl ect a 
parolee’s well-being or functioning in society? 
 3.  What are the ethical implications of implementing (and funding) compulsory treat-
ment for released prisoners in a community where availability of (or funding for) 
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voluntary treatment is currently inadequate? To what extent does lack of access to 
voluntary services (and other social determinants of health such as income and 
education) contribute to the need for compulsory treatment, particularly among 
people who are vulnerable to substance use, incarceration, and infectious disease? 
 4.  Public resources and facilities are already in place to provide involuntary treat-
ment for certain health conditions (e.g., tuberculosis and mental illness). Suppose 
that some mental health advocates object to the proposal to introduce compul-
sory drug treatment by arguing that it would divert funds from treating people 
with serious mental illness, including those with criminal histories. People  with 
 serious mental illness, they contend, constitute a far more vulnerable prison 
group, many of whom have co-occurring substance abuse problems. If true, how 
will your thinking about the case be infl uenced? Why? 
 5.  Suppose someone argues that the compulsory treatment program under consid-
eration is another example of society’s punitive approach to managing substance 
abuse. To what extent do you agree or disagree with this argument? Why? 
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7.10.1  Background 
 Infl uenza is  a  common respiratory pathogen that affects the nose, throat, bronchi 
and lungs. The virus is spread through droplets and small particles when people 
cough or sneeze. Though infl uenza regularly affects people worldwide, the emer-
gence of novel infl uenza virus subtypes has the potential to cause a  pandemic (World 
Health Organization [WHO]  2008 ). In such a case, the population’s low immunity 
can lead the virus to spread rapidly with high rates of sickness and death. Although 
no one can predict when a pandemic will strike, attack rates of 25–45 % have been 
suggested with mortality rates varying greatly depending on the virulence of the 
strain (WHO  2010 ). 
 With a virulent strain of pandemic infl uenza, many patients will become extremely 
ill, and their need for specialized treatment and intensive care may exceed resources. 
In addition, front-line  health care workers will face great risk of becoming ill, dwin-
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dling human resources further and straining the health care system (WHO  2008 ; 
University of Toronto Joint Center for Bioethics  2005 ). In anticipation of these 
human and physical  resource shortages , hospitals, public health agencies, and states 
have created plans to prepare for an infl uenza pandemic. Such plans typically include 
health services, public health measures,  priority setting , and  resource allocation and 
usually direct  surveillance , preparedness, and response (WHO  2010 ). 
 Pan demic plans typically aim to minimize serious illness and overall deaths, but 
more comprehensive plans also refer to special needs of vulnerable groups. The 
term “vulnerable,” however, often is left undefi ned, and, if specifi ed (e.g., the 
elderly), it usually refers to increased biological or medical risk of succumbing to or 
transmitting pandemic infl uenza (Uscher-Pines et al.  2007 ). Few plans refer to vul-
nerability in social or economic terms (Uscher-Pines et al.  2007 ). This lack of speci-
fi city raises questions about whether (and how) special consideration ought to differ 
for vulnerable conditions, such as being homeless, being immunocompromised, or 
living in a remote community. Even when plans do mention such vulnerabilities, 
have decision makers or practitioners consulted the people in these categories about 
their needs in such situations? (Uscher-Pines et al.  2007 ) More importantly, has 
anyone reconciled the aim of minimizing sickness and death with the oft competing 
aim of meeting the needs of the vulnerable? 
 Meeting the needs of the most vulnerable while being mindful of  health equity 
and  social justice has been a long-standing tradition of public health (Beauchamp 
 1976 ; Krieger and Birn  1998 ). In particular, public  health interventions targeting 
the  social determinants of health have been heralded as an effective way to combat 
systemic inequities that lead to disparities in  health outcomes (Wilson  2009 ). 
However, some challenge the notion of vulnerability as a static condition that can 
be predefi ned. Broadly defi ned categories of vulnerability can exclude people not 
traditionally seen as vulnerable (such as  health care workers ), while including peo-
ple thought to be vulnerable who, with the right supports, can actually participate 
in the  emergency response (e.g., retired older adults) (Mastroianni  2009 ). 
Considering and doing something about the context-specifi c needs of those who 
might be most vulnerable during a  pandemic , can easily become a complex, ethi-
cally fraught task. 
 A further complication is that the interventions taken in response to a pandemic 
can unintentionally render some people more vulnerable (Mastroianni  2009 ). Most 
pandemic infl uenza plans, for example, seem to focus on hospitals, directing atten-
tion to managing intensive care unit (ICU) bed and equipment shortages and distrib-
uting resources in high-acuity settings. Such plans often call for redeploying workers 
from community settings to hospital settings. Because many of these workers 
already work part-time in the community and hospital sectors, this option is appeal-
ing. But if workers are shifted from  community health care settings to hospitals, 
people in the community who depend on these workers may become vulnerable 
from the  intervention . 
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7.10.2  Case Description 
 It has been 1 week since the World Health Organization offi cially declared the pres-
ence of an  infl uenza pandemic. Person-to-person spread has been confi rmed in sev-
eral Canadian cities, and emergency rooms in your large metropolitan city overfl ow 
with infl uenza patients. Because routine cases usually fi ll the medical fl oors and 
intensive care units to capacity, there is concern that the surge of infl uenza admis-
sions will overwhelm resources. To set priorities and possibly reallocate resources 
within the health care system, the regional health authority has called a meeting in 
anticipation of the surge in admissions. As the lead of the local health emergency 
management program, you are asked to attend. 
 A  couple  of hours before the meeting, you listen to a call on your answering 
machine from Julia, a friend and the director of the local community care access 
center (home care agency). This is the largest center in the region, employing 600 
and subcontracting 20,000 health and community service workers through other 
agencies.  Profession al services that are subcontracted include in-home nursing, 
occupational therapy, physiotherapy, social work, speech and language therapy, and 
nutritionists; nonprofessional services include personal support workers and health 
care aids and attendants who assist with activities of daily living. 
 Having become aware of the upcoming meeting with the regional health 
authority, Julia wonders why no one from the community-based organizations 
that care for people in home settings has been asked to attend. She appreciates the 
media focus on the available ventilators and ICU beds in local hospitals, but she 
is concerned with the lack of attention on  vulnerable populations in the community. 
She has heard rumors of plans to reallocate some nursing and personal  support 
workers from community settings to acute care hospitals and asks if offi cials have 
considered that such a move may require some people, who normally manage 
their illness at home, to be hospitalized. Convinced that someone representing the 
community should attend  priority-setting discussions, she urges you to advocate 
for such a presence. 
 Thinking on various levels about how you would respond to the message even 
as you plan for the meeting, you are particularly struck by how such decisions 
could adversely affect Julia herself.  Her multiple sclerosis is serious enough to 
require the  daily assistance of a personal support worker to help her get from 
home  to  her offi ce. 
7.10.3  Discussion Questions 
 1.  In what ways does this case challenge conventional notions of who might be 
considered vulnerable during a pandemic? 
 2.  What does Julia’s exclusion from the meeting say about the attitude towards 
vulnerable populations at the administrative level? 
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 3.  How might a decision to shift fi nancial and personnel resources from the com-
munity to the hospital setting deepen the health and social inequities that many 
vulnerable populations already face? 
 4.  Would it be fair for Julia to ask her community workers to work more hours 
because the needs of the community have increased? What if the workers feel 
safer working away from the gravely ill at the hospital and prefer to increase 
community work at the expense of hospital work? 
 5.  If the workers remain in their communities with their patients, it could mean they 
are able to help fewer members of the population than if they attended their shifts 
at the hospital. What is more important, treating more people or giving priority 
to the vulnerable or less privileged? 
 6.  Do those who develop pandemic plans have a responsibility to identify people 
whose vulnerability might increase during a pandemic? If so, how should plan-
ners identify these people? 
 7.  The document you received before the meeting indicated that one of the discus-
sion topics will be priority setting, particularly the scarce resource of ventilators. 
The document proposes that a physical disability should disqualify a person 
from having access to a ventilator. How do you balance the need for rationing 
scarce acute care resources, like ventilators, with social justice values that advo-
cate for the respect and consideration of those who are vulnerable due to system-
atic social disadvantage? How will you discuss this matter with Julia? 
 8.  In light of Julia’s message, how would you begin to identify systemic barriers 
that limit the inclusion of vulnerable populations in planning for a pandemic? 
How would you involve these populations in determining if barriers exist that 
may signifi cantly limit their access to essential health services available to other 
populations during a pandemic? 
 References 
 Beauchamp, D.E. 1976. Public health as social justice.  Inquiry 13(1): 3–14. 
 Krieger, N., and A.E. Birn. 1998. A vision of social justice as the foundation of public health: 
Commemorating 150 years of the spirit of 1848.  American Journal of Public Health 88(11): 
1603–1606. 
 Mastroianni, A.C. 2009. Slipping through the net: Social vulnerability in pandemic planning. 
 Hastings Center Report 39(5): 11–12. 
 University of Toronto Joint Centre for Bioethics. 2005.  Stand on Guard for Thee: Ethical consid-
erations in preparedness planning for pandemic infl uenza.  http://jcb.utoronto.ca/people/docu-
ments/upshur_stand_guard.pdf . Accessed 24 June 2015. 
 Uscher-Pines, L., P.S. Duggan, J.P. Garoon, R.A. Karron, and R.R. Faden. 2007. Planning for an 
infl uenza pandemic: Social justice and disadvantaged groups.  Hastings Center Report 37(4): 
32–39. 
 Wilson, J. 2009. Justice and the social determinants of health: An overview.  Public Health Ethics 
2(3): 210–213. 
7 Vulnerability and Marginalized Populations
230
 World Health Organization (WHO). 2008.  Addressing ethical issues in pandemic infl uenza plan-
ning: Discussion papers.  http://www.who.int/csr/resources/publications/cds_fl u_ethics_5web.
pdf . Accessed 8 May 2013. 
 World Health Organization (WHO). 2010.  Pandemic infl uenza preparedness and response: A 
WHO guidance document.  http://whqlibdoc.who.int/publications/2009/9789241547680_eng.
pdf . Accessed 8 May 2013. 
7.11  C ase 5: Can Asylum Seeking Be Managed Ethically? 
 Karin  Johansson  Blight 
 The Policy Institute 
 Kings College London 
 London ,  UK 
 e-mail: karin.johansson_blight@kcl.ac.uk 
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the author ’ s own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the author ’ s host 
institution . 
7.11.1  Background 
 Migration is a challenge managed against the backdrop of international accords and 
the social and historic circumstances peculiar to each country. The 1948  U niversal 
Declaration of Human Rights (UDHR) states “everyone has the right to seek and to 
enjoy in other countries asylum from persecution” (United Nations  1948 , Article 
14). In 1951, the newly established International Organization for Migration (IOM) 
began promoting “humane and orderly  migration for the benefi t of all,” affi rming 
that all migration can be managed (IOM  2013 ). The  United Nations (U.N.) estimated 
221 million migrants worldwide in 2010 (U.N.  2013 ). EUROSTAT estimated 1.7 
million immigrants, including forced migrants, in the  European Union (EU) in 2011 
(EUROSTAT  2014 ). 
 Sweden , a Nordic country that joined the EU in 1995, has a long tradition of moni-
toring the health of its residents. For example, its National Institute of Public Health, 
the National Board of Health and Welfare, and Statistics  Sweden monitor public 
health trends, and a national center monitors suicide and mental illness (the National 
Centre for Suicide Research and Prevention of Mental Ill-Health). “Health on equal 
terms” is a  political priority in Sweden that aligns with the country’s strongly egalitar-
ian and multicultural traditions dating back more than 300 years (Linell et al.  2013 ; 
Westin  2000 ,  2006 ). However, social contingencies throughout Sweden’s history have 
put pressure on these values and traditions. For example, poor harvests and famine in 
the mid- to late-1800s triggered extensive  emigration , virtually closing borders when 
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emigration ended in the 1930s. In the 1940s, the borders reopened fi rst for  refugees 
from neighboring countries, then, in the 1950s–1960s, for labor immigrants from 
European countries. From the 1970s onward, the focus shifted to family reunifi cation 
of migrants and refugees from outside the EU. According to Statistic Sweden’s fi gures 
from 2012, of its 9.6 million population, about 15 % are foreign born (Statistics 
Sweden  2013 ). The  S wedish Migration Board (SMB) suggests that 16 % of residen-
cies granted in 2012 were on refugee, protection, humanitarian, or similar grounds 
(including temporary grounds) (SMB  2014 ). 
 The term  migration management (MM) was coined in the 1990s, although the 
MM fi eld originated in the 1950s (Widgren  1994 ). The rise of MM coincided with 
a time when several factors, including the mechanisms of colonialism and the  Cold 
War , worked to control and minimize global  migration . But other factors also infl u-
enced MM, such as resettlements after World War II; efforts to safeguard rights of 
 refugees and migrant workers rights led by international organizations (e.g., the 
International Labour Organization, the United  Nations High Commissioner for 
Refugees and the International Organization for  Migration ); and regional initiatives 
that removed immigration barriers to improve national economies (e.g., the 
 Organis ation for Economic Co-operation and Development and the Treaty of 
Rome). In the mid-1970s to mid-1980s,  Western countries jointly attempted to har-
monize entry controls, efforts that the third pillar of the EU’s 1993  Maastricht 
Treaty later incorporated (Maastricht Treaty  1992 ). 
 Policies enacted since this treaty have focused on deterring unwanted migrants, 
arguably to the detriment of  human rights and  refugee protections (Fekete  2001 ). By 
2002, experts suggested that reducing unwanted and unauthorized  immigration could 
increase public support for integration assistance for foreign residents in Western 
countries (Martin and Widgren  2002 ). But this focus on reduction had the side effect 
of criminalizing “unwanted” migrants. By implying that unwanted migrants could 
pose a national security threat, policy instruments such as the 2006 Schengen Borders 
Code may have fed xenophobic tendencies (Schengen Borders Code  2010 ). Article 
5 in the code includes, for example, a statement about entry conditions for short- stay, 
third-country nationals, that they are not “… considered to be a threat to public pol-
icy, internal security, public health, or the international relations of any of the Member 
States.” At any rate, such increased  deterrence  and control measures do restrict 
access to work, housing, health care, and independent legal advice, and even sepa-
rates families (Johansson Blight et al.  2009 ). Not surprisingly,  detention policies 
harm health with disproportionately high rates of poor  mental health , suicide, and 
self-harm amongst detainees (Silove et al.  2000 ; Cohen  2008 ). Moreover, evidence 
suggests that such controls have resulted in the rejection of asylum claims of torture 
survivors and people with severe health problems (Steel et al.  2006 ; Migration Court 
of Appeal  2007 ; Johansson Blight  2015 ). The evidence also suggests that controls 
led to  children suffering due to exacerbated vulnerability in detention and to unac-
counted deaths of forced migrants at  Western country borders (Grewcock  2009 ; Steel 
et al.  2011 ). These injustices prompted repeated appeals to national  law , the UDHR, 
and the Convention on the Rights of the Child and calls for change to relevant World 
Medical Association (WMA) documents such as the Geneva and Lisbon declarations 
(Hunt  2007 ; Bodegård  2014 ; Johansson Blight  2014 ; Johansson Blight et al.  2014 ). 
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 An especially poignant example of the health challenges found among  asylum 
seekers , especially children, is the condition known as  pervasive arousal withdrawal 
syndrome (PAWS) (Bodegård  2014 ). This condition presents as pervasive loss of 
functioning and profound social withdrawal and  apathy (Söndergaard et al.  2012 ; 
Envall  2013 ; Bodegård  2014 ; Johansson Blight  2014 ; Johansson Blight et al.  2014 ). 
Few children show signs of severe PAWS upon arrival in  Sweden ; however, routine 
data on incidence and prevalence are lacking (Envall  2013 ). Surveys conducted in 
the past 10 years have identifi ed anywhere from 30 to 424 children with this condi-
tion (Envall  2013 ). Common predictors include exposure to severe persecution, 
 human rights abuses or other traumatic experiences in the country of origin, and the 
prospect of  deportation to countries with poor  human rights records. Other signs of 
distress include suicide attempts (Johansson Blight  2014 ). PAWS commonly affects 
health and functioning gradually, over time rendering a child unresponsive and 
unable to eat or drink without support, which makes the condition life-threatening. 
Unfortunately, the required health assessment of  asylum seekers is insuffi cient for 
detecting PAWS in its early stages (Johansson Blight  2014 ). Typically, static mea-
sures of health (such as the use of yes/no check boxes) are used, and life events such 
as  discrimination , traumatizing episodes, or prolonged stress carry little weight in 
the health evaluation process requested by the  migration authorities. From a health 
perspective, broader and more culturally appropriate assessments are recommended 
instead, such as illness narratives, family medical history taking, and recording of 
past and present social contexts (Bhugra et al.  2010 ). If adopted, more cases of 
 P AWS could be identifi ed, prevented, and treated. No cases of  children dying with 
PAWS have been reported in  Sweden , but there has been no systematic follow-up of 
children deported from Sweden (Envall  2013 ). 
7.11.2  Case Description 
 The Swedish Migration Board (SMB), the ultimate authority on  deportation of  asy-
lum seekers , announced it no longer deports children with PAWS. After this 
announcement, however, the media reported on a rejected asylum seeker, a 14-year- 
old Roma girl 1 with the condition, deported with her family to their country of ori-
gin (Edquist  2013 ; Myhrén  2013 ). During deportation, the girl who had lost all 
ability to function, was being fed through a feeding tube, and was unresponsive to 
pain. Upon arrival at their home country, the family was refused entry due to the 
girl’s advanced illness and was eventually forced to return to Sweden. 
 A family friend in  Sweden said that widespread persecution of  Roma people in 
the family’s home country had restricted the 14-year-old girl’s life. For example, the 
girl had never attended  school because her  parent s feared she would be ostracized, 
teased, ridiculed, or even physically hurt. The friend explained that the symptoms of 
1  The  Roma people are an ethnic group who trace their origin to the Indian subcontinent, some-
times referred to as gypsies. 
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severe PAWS began the previous month after Swedish police visited the family’s 
home in  Swed en. 
 According to the SMB, the police who enforced the  deportation reported that when 
they fi rst visited the family, the girl was attending  school , and although said to be some-
what shy and withdrawn, she appeared relatively healthy. A routine health assessment 
of  asylum seekers to assess barriers to enforcing deportation found no medical or other 
reason to impede deportation. This claim confl icted with the statement of a therapist 
working for a  human rights organization, who said he had informed the SMB about the 
girl’s history of  discrimination ,  trauma , and her state of complete function loss, which 
included her inability to communicate and engage in social interaction. In their defense, 
police say they followed standard procedures and stand by the initial assessment 
regarding deportation, which prompted no grounds for halting deportation. 
 Upon returning to  Sweden , the family was detained in an  immigration facility, 
where the father at fi rst was separated from the family. At the time of the media 
reports, the family had been reunited and was awaiting a new SMB decision on 
whether they should again be deported. 
 You are a member of a commission established to decide the outcome of this case 
and come up with ways to improve the asylum and deportation system. Other mem-
bers of the commission include medical offi cers, public health offi cials, lawyers, 
 and former immigration offi cials. 
7.11.3  Discussion Questions 
 1.  Who are the main  stakeholder s and organizations in this case? What are their 
primary interests and obligations? 
 2.  What bearing does vulnerability or increased risk of harm have on public health’s 
obligation to prevent or mitigate harm to an individual? What impact should 
legal status have on that obligation? 
 3.  What are the goals of the asylum and deportation process, and what are the val-
ues that drive these goals? How should these values be prioritized? 
 4.  What decision would you make in this case? 
 5.  Based on your prioritization of values, what recommendations would you make 
to improve the asylum and deportation system? 
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7.12  Case 6:  Tubercu losis Screening, Testing, and Treatment 
among Asylum Seekers 
 Christopher  W.  McDougall 
 Institute of Health Policy, Management and Evaluation, 
and Joint Centre for Bioethics 
 University of Toronto 
 Toronto ,  ON ,  Canada 
 e-mail: christopher.mcdougall@utoronto.ca 
 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the author’s own. The case is not meant to refl ect the offi cial position, views, or 
policies of the editors, the editors’ host institutions, or the author’s host institution. 
7.12.1  Background 
 Tuberculosis (TB), an airborne transmissible bacterial infection that most commonly 
affects the lungs, has been dubbed “the greatest killer in history” and one of “human-
kind’s worst enemies” (Selgelid  2008 ). TB is typically contracted after prolonged 
close exposure to the coughing and sneezing of people with active infections. 
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Although only 5–10 % of people who are infected (but who are not  HIV positive) 
become sick or infectious at some point during their lives, untreated TB kills about 
two-thirds of those it does infect, despite the availability of effective medicines since 
the 1950s (World Health Organization [WHO]  2012 ). Since 1995, the WHO stan-
dard for treatment has been  directly observed therapy, short-course (DOTS) , which 
involves people watching patients swallowing their pills. Treatments delivered 
through DOTS are inexpensive and 95 % effective, although 6–9 months may be 
required to cure ordinary  acti ve or latent strains of the infection (Minion et al.  2013 ). 
 Inconsistent or partial treatment—when patients do not take their medicines 
regularly for the required period because they start to feel better, because doctors 
and health workers prescribe the wrong treatment regimens, or because  drug supply 
is unavailable due to  cost or unreliable due to lack of  regulation —has led to TB 
strains that resist one or more fi rst-line drugs (i.e., those most effective and least 
likely to cause adverse side effects). Drug-resistant TB has been documented in 
every country surveyed (WHO  2012 ). A particularly dangerous form of drug- 
resistant TB is  multidrug-resistant TB (MDR-TB) , defi ned as the disease caused by 
TB bacilli resistant to at least isoniazid and rifampicin, the two standard anti-TB 
drugs. Curing MDR strains of the bacteria is much less  effective (with a 30–40 % 
failure rate in Canada, slightly better than the global average of 52 %, according to 
Minion et al.  2013 ), costs much more, produces reactions that diminish  compliance , 
and may take as long as 20–24 months (Public Health Agency of Canada.  2014 ). 
MDR-TB accounts for 1.2 % of all TB cases in Canada, for example, and typically 
 cost s fi ve times as much ($250,000 vs $47,290 per patient) (Public Health Agency 
of Canada  2014 ; Menzies et al.  2008 ). 
 TB has retained dramatically high levels of incidence, prevalence, and morbidity 
and mortality worldwide, especially in developing countries, because social,  politi-
cal , and economic factors (rather than simply biological ones) play key roles in  infec-
tious disease patterns. Recent global estimates put the numbers at 15 million active, 
and perhaps 2 billion latent (asymptomatic) infections, with 9 million new infections 
yearly, and 1.5 to 2 million deaths per year (95 % of which occur in  sub- Saharan 
Africa and Asia) (WHO  2012 ). TB is the world’s leading cause of preventable death 
among young adults, and the leading cause of death among those who are  HIV posi-
tive, since the infection tends to affect and progress quickly in those whose immune 
systems are compromised by other conditions, particularly HIV but also  measles , 
malaria, or alcoholism. TB is thus often referred to as a “classic social disease” and 
a “disease of poverty” because of its association with overcrowding, malnutrition, 
stress, destitution, and rapid social change. TB has also been dubbed the forgotten 
plague because it rarely affects the wealthy, who are largely insulated from exposure 
(Kim et al.  2005 ; Ryan  1993 ). Thus, although TB was extremely common in eigh-
teenth- and nineteenth-century England throughout the industrial revolution, infec-
tion rates declined substantially when housing,  sanitation , nutrition, and labor 
conditions improved and endemic infections all but disappeared in developed coun-
tries well before effective drugs were widely available (Selgelid  2008 ). 
 TB, though relatively uncommon in Canada today with around 1,600 cases 
reported annually, is costly ($58 million in direct costs, and $74 million total related 
expenditure, in Canada in 2004) (Menzies et al.  2008 ), frequently results in hospital 
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admission, and retains an 11 % mortality rate (Greenaway et al.  2011 ).  Fore ign-born 
 persons  account for 65 % of active TB, although they make up only 20 % of the 
population. Up to half of recent immigrants and  refugees to Canada are estimated to 
harbor latent TB and are thus at risk of progressing  to  active infection, and TB in 
refugee populations is about double that in other classes of immigrant populations 
(Greenaway et al.  2011 ). Those most at risk domestically are the urban homeless 
and aboriginal communities, followed by residents of long-term care and correc-
tional facilities, and then the staff who work in such institutions (Public Health 
Agency of Canada  2014 ). 
 The cornerstone of TB ethics, according to the WHO, is the protection of indi-
viduals and communities through the proper treatment of infected individuals 
( active  and latent) and the  prevention of new infections. These goals are said to 
rely on the promotion of key values including  social justice and  equity ,  solidarity , 
the common good,  autonomy , reciprocity,  effectiveness , subsidiarity,  participa-
tion , and transparency and accountability (WHO  2010 ). The WHO also stresses, 
in cases where involuntary isolation or detention measures are implemented, the 
importance of using the least restrictive means necessary to achieve public health 
goals, as set forth in the  Siracusa Principles . These principles require states to 
ensure that such interventions are proportional to the risk of public harm, neces-
sary and relevant to protecting the public good, and applied without  discrimina-
tion (WHO  2010 ). 
7.12.2  Case Description 
 On a chilly gray autumn morning, Canadian Coast Guard offi cials take into cus-
tody 77 people (66 men, and 11 boys between 8 and 16 years of age) after their 
vessel, suspected to have been abandoned by human smugglers, is found adrift off 
the northwest Pacifi c coast. All immediately claim  refugee status and are trans-
ferred to a provincial prison, the nearest facility judged suffi ciently secure to detain 
them, review their claims, and physically examine them per  immigration proce-
dures. Overcrowding at the criminal correction center, already an issue, becomes 
severe with the addition of these individuals, many of whom are housed four or fi ve 
to cells designed for only two people, and often in portable trailers parked in the 
prison yard. The asylum seekers are subject to the same institutional rules as crimi-
nal detainees: they must wear prison uniforms and are signifi cantly restricted in 
making or receiving telephone calls (Nakache  2011 ). The federal Refugee 
Protection Division and provincial health authorities jointly appoint you as a mem-
ber of an ad hoc local public health unit task force  responding to the situation. 
 Canadian  immigration  law requires asylum seekers in the country to undergo a 
medical examination, including screening to assess potential burden of illness, 
linked to ongoing  surveillance or clinical actions only for TB,  syphilis , and  HIV 
(Gushulak et al.  2011 ; Gardam et al.  2014 ). Within 48 h, medical examinations and 
chest X-ray results suggest active TB in four of the new detainees: two adults and 
two brothers ages 6 and 11. Based on their overall health conditions and patient 
7 Vulnerability and Marginalized Populations
238
histories (to the extent that these can be verifi ably ascertained under the circum-
stances) and TB epidemiology in the region of origin, the medical team strongly 
suspects all four to be infected with MDR-TB, and cultures are thus ordered. The 
tests will take 2 weeks before results can confi rm the presence of drug-resistant 
strains (6 weeks are needed to confi rm negative cultures). 
 The  Canadian Immigration and Refugee Protection Act (IRPA) (Government of 
Canada  2001 ) and accompanying  regulations (Government of Canada  2013 ) stipu-
late that people likely to be a danger to public health or a “public charge” (defi ned 
as likely to make excessive demands on health or social services but likely unable 
or unwilling to support themselves) may be deemed inadmissible for refugee sta-
tus. However, considerable discretionary power, particularly for  children and oth-
ers in need of protection, is built into the law and related regulations, and initial 
decisions by immigration offi cers are generally subject to appeal (Bailey et al. 
 2005 ; Greenaway et al.  2011 ). Section 249 of the IRPA regulations, moreover, sets 
out special requirements for minor refugee claimants, including the  duty to con-
sider the availability of local childcare arrangements, of segregated spaces in 
detention centers, and of education, counseling, and  recreational  ser vices 
(Government of Canada  2013 ). 
7.12.3  Discussion Questions 
 1.  Although all 77 refugee claimants have been screened for TB, they have not been 
tested for TB. Given the journey and conditions just endured by this group on 
board the cramped vessel, should the task force advise local public health author-
ities to test all claimants for active or latent TB? Why or why not? 
 2.  What recommendations should the task force make concerning ongoing detain-
ment conditions? What information should be provided to the current residents 
and staff of the regional corrections center? 
 3.  Given the clinicians’ conclusions, should second-line TB treatment be immedi-
ately offered to the four affected refugees? If they refuse treatment, should treat-
ment be compelled? How and why? 
 4.  When news breaks locally of the TB status of the two young brothers, commu-
nity leaders of the same ethnic background offer to shelter the boys and oversee 
their treatment. Discuss the relevance of the principle of “least restrictive means” 
to such a scenario, and indicate when or whether local public health authorities 
should consider community care and support approaches to MDR-TB 
treatment. 
 5.  Three months into their detainment, the claims of several refugees are rejected. 
Hunger strikes and violence among the detainees ensue. How should the task 
force respond? 
 6.  Consider a scenario in which the status of one of the two adults suspected of being 
infected by MDR-TB is subsequently confi rmed and the patient is denied refugee 
status as well. What are the  cost s and risks of the repatriation of MDR- TB cases 
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compared with standard TB cases? Do the task force, public health  auth orities, 
and provincial or federal authorities have any obligations under such a scenario? 
 7.  How should the goals of public health and those of immigration policy be 
balanced? 
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